Metastatic Mucinous Adenocarcinoma of Unknown Origin Showing 68 Ga-DOTATATE Uptake.

IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Clinical Nuclear Medicine Pub Date : 2025-01-01 Epub Date: 2024-10-30 DOI:10.1097/RLU.0000000000005548
Nuh Filizoglu, Salih Ozguven, Fuat Dede, Halil Turgut Turoglu, Tanju Yusuf Erdil
{"title":"Metastatic Mucinous Adenocarcinoma of Unknown Origin Showing 68 Ga-DOTATATE Uptake.","authors":"Nuh Filizoglu, Salih Ozguven, Fuat Dede, Halil Turgut Turoglu, Tanju Yusuf Erdil","doi":"10.1097/RLU.0000000000005548","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Although the use of 18 F-FDG PET/CT is well established in the evaluation of adenocarcinoma, the performance of 18 F-FDG PET/CT in mucinous adenocarcinoma is not consistent. 68 Ga-DOTATATE uptake can be observed in some non-neuroendocrine tumors as a result of tumor blood flow and somatostatin receptor expression at different levels. For this reason, 68 Ga-DOTATATE PET/CT may have a prospective role in the evaluation of mucinous adenocarcinoma. However, there is no published case of mucinous adenocarcinoma with 68 Ga-DOTATATE uptake. We present a unique case of metastatic mucinous adenocarcinoma of unknown origin on 68 Ga-DOTATATE PET/CT.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e51-e52"},"PeriodicalIF":9.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/RLU.0000000000005548","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: Although the use of 18 F-FDG PET/CT is well established in the evaluation of adenocarcinoma, the performance of 18 F-FDG PET/CT in mucinous adenocarcinoma is not consistent. 68 Ga-DOTATATE uptake can be observed in some non-neuroendocrine tumors as a result of tumor blood flow and somatostatin receptor expression at different levels. For this reason, 68 Ga-DOTATATE PET/CT may have a prospective role in the evaluation of mucinous adenocarcinoma. However, there is no published case of mucinous adenocarcinoma with 68 Ga-DOTATATE uptake. We present a unique case of metastatic mucinous adenocarcinoma of unknown origin on 68 Ga-DOTATATE PET/CT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
显示 68Ga-DOTATATE 摄取的不明来源转移性黏液腺癌
摘要:虽然18F-FDG PET/CT在腺癌评估中的应用已得到广泛认可,但18F-FDG PET/CT在黏液腺癌中的表现并不一致。在一些非神经内分泌肿瘤中可观察到 68Ga-DOTATATE 摄取,这是肿瘤血流和体泌素受体表达水平不同的结果。因此,68Ga-DOTATATE PET/CT 可能在粘液腺癌的评估中具有前瞻性作用。然而,目前还没有一例已发表的粘液腺癌具有 68Ga-DOTATATE 摄取。我们介绍了一例在 68Ga-DOTATATE PET/CT 上显示来源不明的转移性粘液腺癌的独特病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Nuclear Medicine
Clinical Nuclear Medicine 医学-核医学
CiteScore
2.90
自引率
31.10%
发文量
1113
审稿时长
2 months
期刊介绍: Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.
期刊最新文献
18F-FDG PET/CT Incidental Finding of Rare Extrapulmonary Presentation of Mycobacterium tuberculosis. A Case Report: PSMA PET/CT in Retroperitoneal Hemangioma. An Unexpected Mediastinal Fibrosis Case Detected and Evaluated of Treatment Response With 18F-FDG PET/CT. FDG PET/CT Scan Still Can Help in Evaluation of Prostate Cancer. First Successful In-Human Application of 225Ac-DOTA-LM3 Mono-PRRT for the Treatment of an Otherwise Therapy-Resistant Neuroendocrine Tumor (NET G3).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1